Top Markets
#1 Black Phoenix Black Phoenix +852.80%
#2 Nesa Nesa +536.74%
#3 QuantixAI QuantixAI +103.24%
#4 MetaDAO MetaDAO +29.58%
#5 Ontology Gas Ontology Gas +23.90%
#6 Bedrock Bedrock +18.10%
#7 Stacks Stacks +13.77%
#8 peaq peaq +13.54%
#9 Humanity Humanity +13.42%
#10 Moolah Moolah +13.24%
Coin of the day
Black Phoenix Black Phoenix
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Catalent, Inc. Catalent, Inc.

Catalent, Inc.

CTLT
Kedudukan dalam Saham #1926
Catalent, Inc., operating globally through its various subsidiaries,... Catalent, Inc., operating globally through its various subsidiaries, specializes in the development and production of comprehensive solutions for a wide array of products, including pharmaceutical drugs, protein-based biologics, advanced cell and gene therapies, and consumer health items. The company's operations are strategically divided into four key segments: Biologics; Softgel and Oral Technologies; Oral and Specialty Delivery; and Clinical Supply Services. The Softgel and Oral Technologies division focuses on the formulation, development, and manufacturing of soft capsules. These are utilized in a diverse range of client products, such as prescription medications, over-the-counter drugs, nutritional supplements, unit-dose cosmetics, and medicinal preparations for animal health. Within the Biologics segment, Catalent undertakes the creation of biologic cell lines, develops and manufactures both cell therapy and viral-based gene therapy, and handles the formulation and production of parenteral dose forms, including vials, prefilled syringes, and cartridges. This segment also provides essential analytical development and testing capabilities. The Oral and Specialty Delivery segment offers extensive formulation, development, and manufacturing expertise across various technologies. It provides integrated downstream solutions spanning clinical development and commercial supply. This segment also features a dedicated oral delivery solutions platform, encompassing preclinical screening, formulation, analytical development, and current good manufacturing practices (cGMP) services. Finally, the Clinical Supply Services segment delivers vital support for drug and biologic clinical trials. Its services include manufacturing, specialized packaging, secure storage, efficient distribution, and comprehensive inventory management. This segment also offers "FastChain," a demand-led clinical supply service. Catalent serves a broad client base, including pharmaceutical, biotechnology, and consumer health organizations, alongside companies in other healthcare sectors like animal health and medical devices, and even the cosmetics industry. The company was founded in 2007 and maintains its headquarters in Somerset, New Jersey.
Harga Saham
$63.48
Disegerakkan terakhir: 2024-12-17
Modal Pasaran
$11.52B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Catalent, Inc. (CTLT)

Kategori

Healthcare
Nisbah P/E bagi Catalent, Inc. (CTLT)
Nisbah P/E pada August 2026 TTM: -11.02
Menurut laporan kewangan dan harga saham terkini Catalent, Inc., nisbah P/E semasa (TTM) ialah -11.02. Pada akhir 2023, syarikat mempunyai nisbah P/E sebanyak -33.83.
Sejarah nisbah P/E bagi Catalent, Inc. dari 2011 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
2026 (TTM) -11.02 13.03%
2024 -9.75 -71.19%
2023 -33.83 -189.39%
2022 37.84 21.87%
2021 31.05 -51.08%
2020 63.47 10.50%
2019 57.44 -12.63%
2018 65.74 64.52%
2017 39.96 55.29%
2016 25.73 55.29%
2015 16.57 -88.55%
2014 144.74 -388.22%
2013 -50.22 -47.75%
2012 -96.12 121.31%
2011 -43.43 0.00%
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 38.29 -447.40%
IN
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.